Albumin (Solution) Instructions for Use
ATC Code
B05AA01 (Albumin)
Active Substance
Human albumin (BP British Pharmacopoeia)
Clinical-Pharmacological Group
Plasma substitute. Human albumin preparation
Pharmacotherapeutic Group
Blood substitutes and perfusion solutions; blood products and related agents; blood substitutes and plasma protein fractions
Pharmacological Action
A preparation obtained by fractionation of blood, plasma, placenta, or serum from healthy donors.
It maintains the colloid-osmotic (oncotic) pressure of the blood, increases the circulating blood volume, and raises blood pressure.
It promotes the movement of tissue fluid into the bloodstream and is a source of protein.
Indications
Traumatic and postoperative shock, burns accompanied by dehydration and hemoconcentration, hypoproteinemia and hypoalbuminemia developing in nutritional dystrophy, nephrotic syndromes, glomerulonephritis, liver cirrhosis, prolonged purulent processes, and lesions of the gastrointestinal tract with impaired patient nutrition (including peptic ulcer disease, tumors).
ICD codes
| ICD-10 code | Indication |
| C15-C26 | Malignant neoplasms of digestive organs (C15-C26) |
| D13 | Benign neoplasm of other digestive organs |
| E86 | Volume depletion (including dehydration, hypovolemia) |
| E88.0 | Plasma protein metabolism disorders, not elsewhere classified |
| K25 | Gastric ulcer |
| K26 | Duodenal ulcer |
| K74 | Fibrosis and cirrhosis of liver |
| N00 | Acute nephritic syndrome (acute glomerulonephritis) |
| N03 | Chronic nephritic syndrome |
| N04 | Nephrotic syndrome |
| T30 | Burns and corrosions of unspecified body region |
| T79.4 | Traumatic shock |
| ICD-11 code | Indication |
| 2C1Z | Malignant neoplasms of digestive organs, unspecified |
| 2E92.Z | Benign neoplasm of unspecified digestive organs |
| 5C5A | Alpha-1-antitrypsin deficiency |
| 5C70.Z | Decrease of volume of fluid [hypovolemia], unspecified |
| 5D0Y | Other specified metabolic disorders |
| 5D2Z | Metabolic disorders, unspecified |
| DA60.Z | Gastric ulcer, unspecified |
| DA63.Z | Duodenal ulcer, unspecified |
| DB93 | Fibrosis or cirrhosis of liver |
| GB40 | Nephritic syndrome |
| GB41 | Nephrotic syndrome |
| NE11 | Burn of unspecified body region |
| NF0A.4 | Traumatic shock, not elsewhere classified |
| GB40 | Nephritic syndrome |
| XT8W | Chronic course |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Determine the dose and infusion rate individually based on the patient’s condition, laboratory values, and response to therapy.
Administer the solution intravenously only. Do not use if the solution is cloudy or contains precipitates.
For hypovolemic shock, administer an initial bolus dose rapidly. Titrate subsequent doses to the desired clinical response, such as stabilization of hemodynamic parameters.
For hypoalbuminemia, calculate the required dose based on the patient’s body weight and the target serum albumin increase. Infuse at a slower rate to minimize the risk of circulatory overload.
Adjust the infusion rate for elderly patients and those with compromised cardiac or renal function. Monitor for signs of hypervolemia, including hypertension, dyspnea, and pulmonary edema.
In pediatric patients, base the dose on body weight or body surface area. Closely monitor vital signs and fluid status during and after administration.
For burns, administer as part of a comprehensive fluid resuscitation protocol. The volume and timing depend on the extent of the burn and the patient’s fluid and protein losses.
Do not dilute the solution with water for injections; this may cause hemolysis in recipients. Use only compatible infusion solutions, such as 0.9% sodium chloride or 5% dextrose.
Complete the infusion within 4 hours of piercing the container’s closure. Discard any unused portion.
Adverse Reactions
From the digestive system: nausea, vomiting, hypersalivation are possible.
From the cardiovascular system: arterial hypotension, tachycardia.
Allergic reactions: urticaria is possible; rarely – anaphylactic shock.
Others: increased body temperature, pain in the lumbar region are possible.
Contraindications
Thrombosis, arterial hypertension, ongoing internal bleeding, severe anemia, severe forms of heart failure, hypersensitivity to human albumin.
Use in Pregnancy and Lactation
During pregnancy, human albumin should be used only in cases of extreme necessity.
Data on the safety of human albumin use during lactation are not available.
Use in Hepatic Impairment
Can be used depending on the clinical situation.
Use in Renal Impairment
Can be used depending on the clinical situation.
Pediatric Use
Can be used depending on the clinical situation.
Geriatric Use
Use with caution in elderly patients due to the risk of cardiovascular system overload.
Special Precautions
Patients with dehydration should be provided with adequate fluid intake before administration of human albumin.
Use with caution in patients with reduced cardiac reserve due to an increased risk of acute heart failure.
When using preparations made from human blood and plasma, the possibility of transmitting infectious diseases cannot be completely excluded.
Drug Interactions
Concomitant use of human albumin with ACE inhibitors increases the risk of arterial hypotension.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Bryansk Regional Blood Transfusion Station (Russia)
Dosage Form
 |
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 10% (5 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Bryansk Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (5 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 5 g |
50 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 10% (20 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Bryansk Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Vologda Regional Blood Transfusion Station No. 1 State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 10% (1 g/10 ml): amp. 10 pcs.
Marketing Authorization Holder
Vologda Regional Blood Transfusion Station No. 1 State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (1 g/10 ml): amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 amp. |
| Human albumin | 100 mg | 1 g |
10 ml – ampoules (10) – cardboard packs.
Solution for infusion 10% (2 g/20 ml): amp. 10 pcs.
Marketing Authorization Holder
Vologda Regional Blood Transfusion Station No. 1 State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (2 g/20 ml): amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 amp. |
| Human albumin | 100 mg | 2 g |
20 ml – ampoules (10) – cardboard packs.
Solution for infusion 10% (20 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Vologda Regional Blood Transfusion Station No. 1 State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 20%: amp. 10 or 20 ml, fl. 50 ml or 100 ml
Marketing Authorization Holder
Ivanovo Regional Blood Transfusion Station SIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 20%: amp. 10 or 20 ml, fl. 50 ml or 100 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml |
| Human albumin | 200 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
Solution for infusion 20%: bottle 50 mL or 100 mL
Marketing Authorization Holder
Immune-Hem, CJS (Russia)
Manufactured By
Tyumen Regional Blood Transfusion Station (Russia)
Or
Immune-Hem, CJS (Russia)
Dosage Form
|
Albumin | Solution for infusion 20%: bottle 50 mL or 100 mL |
Dosage Form, Packaging, and Composition
Solution for infusion transparent or slightly opalescent, yellow, amber, or greenish in color.
| 1 ml | |
| Human albumin | 200 mg |
Excipients: sodium caprylate not more than 0.23 mmol/g, sodium chloride 90-160 mmol/l, water for injections up to 1 l.
50 ml – glass bottles (1) – cardboard packs.
100 ml – glass bottles (1) – cardboard packs.
Solution for infusion 10% (10 g/100 mL): bottle 1 pc.
Marketing Authorization Holder
Kirov Research Institute of Hematology and Blood Transfusion of Roszdrav, FSU (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 mL): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – bottles (1) – cardboard packs.
Solution for infusion 10% (20 g/200 mL): bottle 1 pc.
Marketing Authorization Holder
Kirov Research Institute of Hematology and Blood Transfusion of Roszdrav, FSU (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 mL): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – bottles (1) – cardboard packs.
Solution for infusion 10% (40 g/400 mL): bottle 1 pc.
Marketing Authorization Holder
Kirov Research Institute of Hematology and Blood Transfusion of Roszdrav, FSU (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (40 g/400 mL): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 40 g |
400 ml – bottles (1) – cardboard packs.
Solution for infusion 10% (5 g/50 mL): bottle 1 pc.
Marketing Authorization Holder
Kirov Research Institute of Hematology and Blood Transfusion of Roszdrav, FSU (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (5 g/50 mL): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 5 g |
50 ml – bottles (1) – cardboard packs.
Solution for infusion 10%: fl. 50 ml, 100 ml or 200 ml
Marketing Authorization Holder
Lipetsk Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10%: fl. 50 ml, 100 ml or 200 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml |
| Human albumin | 100 mg |
50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Nizhny Novgorod Regional Blood Transfusion Station Named After N.Ya.Klimova SBIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (2 g/20 ml): bottle 1 pc.
Marketing Authorization Holder
Nizhny Novgorod Regional Blood Transfusion Station Named After N.Ya.Klimova SBIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (2 g/20 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 2 g |
20 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (5 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Nizhny Novgorod Regional Blood Transfusion Station Named After N.Ya.Klimova SBIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (5 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 5 g |
50 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (20 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Nizhny Novgorod Regional Blood Transfusion Station Named After N.Ya.Klimova SBIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (10 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Nizhny Novgorod Regional Blood Transfusion Station Named After N.Ya.Klimova SBIH (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (10 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
50 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (5 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (5 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 5 g |
50 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (20 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (40 g/400 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (40 g/400 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 40 g |
400 ml – blood substitute bottles (1) – cardboard packs.
Infusion solution 5% (2.5 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (2.5 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 2.5 g |
50 ml – blood substitute bottles (1) – cardboard packs.
Infusion solution 5% (5 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (5 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 5 g |
100 ml – blood substitute bottles (1) – cardboard packs.
Infusion solution 5% (10 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (10 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 10 g |
200 ml – blood substitute bottles (1) – cardboard packs.
Infusion solution 5% (20 g/400 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (20 g/400 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 20 g |
400 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (10 g/50 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (10 g/50 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 10 g |
50 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (20 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (20 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 20 g |
100 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (40 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (40 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 40 g |
200 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (80 g/400 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (80 g/400 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 80 g |
400 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Manufactured By
ImBio Nizhny Novgorod State Enterprise for the Production of Bacterial Preparations (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – blood substitute bottles (1) – cardboard packs.
100 ml – blood and blood substitute bottles (1) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): fl. 1 pc. (Virion)
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Manufactured By
Virion NPO (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): fl. 1 pc. (Virion) |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – blood substitute bottles (1) – cardboard packs.
100 ml – blood and blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (20 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Manufactured By
Virion NPO (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (20 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 20 g |
100 ml – blood substitute bottles (1) – cardboard packs.
Solution for infusion 20% (20 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Microgen NPO, JSC (Russia)
Manufactured By
ImBio Nizhny Novgorod State Enterprise for the Production of Bacterial Preparations (Russia)
Dosage Form
|
Albumin | Solution for infusion 20% (20 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml | 1 bottle |
| Human albumin | 200 mg | 20 g |
100 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 5%: amp. 10 or 20 ml 5 or 10 pcs., bottle 50 ml, 100 ml or 200 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Infusion solution 5%: amp. 10 or 20 ml 5 or 10 pcs., bottle 50 ml, 100 ml or 200 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml |
| Human albumin | 50 mg |
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
200 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 10%: amp. 10 or 20 ml 5 or 10 pcs., fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Infusion solution 10%: amp. 10 or 20 ml 5 or 10 pcs., fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml |
| Human albumin | 100 mg |
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
200 ml – bottles for blood substitutes (1) – cardboard packs.
400 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 20%: amp. 10 or 20 ml 5 or 10 pcs., bottle 50 ml or 100 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Solution for infusion 20%: amp. 10 or 20 ml 5 or 10 pcs., bottle 50 ml or 100 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml |
| Human albumin | 200 mg |
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 5%: amp. 10 or 20 ml 10 pcs.; fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Infusion solution 5%: amp. 10 or 20 ml 10 pcs.; fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml |
| Human albumin | 50 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
200 ml – bottles for blood substitutes (1) – cardboard packs.
400 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 10%: amp. 10 or 20 ml 10 pcs., fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Infusion solution 10%: amp. 10 or 20 ml 10 pcs., fl. 50 ml, 100 ml, 200 ml or 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml |
| Human albumin | 100 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs.
Infusion solution 20%: amp. 10 or 20 ml 10 pcs., fl. 50 ml or 100 ml 1 pc.
Marketing Authorization Holder
Sverdlovsk Regional Blood Transfusion Station State Healthcare Institution (Russia)
Dosage Form
|
Albumin | Infusion solution 20%: amp. 10 or 20 ml 10 pcs., fl. 50 ml or 100 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml |
| Human albumin | 200 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 20%: fl. 100 ml
Marketing Authorization Holder
Tambov Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 20%: fl. 100 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 20% | 1 ml |
| Human albumin | 200 mg |
100 ml – bottles (1) – cardboard packs.
Infusion solution 10%: fl. 100 ml or 200 ml
Marketing Authorization Holder
Tambov Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Infusion solution 10%: fl. 100 ml or 200 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml |
| Human albumin | 100 mg |
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
Solution for infusion 10% (1 g/10 ml): amp. 10 pcs.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (1 g/10 ml): amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 amp. |
| Human albumin | 100 mg | 1 g |
10 ml – ampoules (10) – cardboard packs.
Solution for infusion 10% (2 g/20 ml): amp. 10 pcs.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (2 g/20 ml): amp. 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 amp. |
| Human albumin | 100 mg | 2 g |
20 ml – ampoules (10) – cardboard packs.
Solution for infusion 10% (10 g/100 ml): bottle 1 pc.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (10 g/100 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 10 g |
100 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 10% (20 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Solution for infusion 10% (20 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 10% | 1 ml | 1 bottle |
| Human albumin | 100 mg | 20 g |
200 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 5% (10 g/200 ml): bottle 1 pc.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (10 g/200 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 10 g |
200 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 5% (20 g/400 ml): bottle 1 pc.
Marketing Authorization Holder
Tyumen Regional Blood Transfusion Station (Russia)
Dosage Form
|
Albumin | Infusion solution 5% (20 g/400 ml): bottle 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion 5% | 1 ml | 1 bottle |
| Human albumin | 50 mg | 20 g |
400 ml – bottles for blood substitutes (1) – cardboard packs.
Solution for infusion 100 mg/1 ml: amp. 10 ml or 20 ml 10 pcs., bot. 50 ml, 100 ml, 200 ml or 400 ml 1 pc.
Marketing Authorization Holder
Chelyabinsk Regional Blood Transfusion Station SUE (Russia)
Dosage Form
|
Albumin | Solution for infusion 100 mg/1 ml: amp. 10 ml or 20 ml 10 pcs., bot. 50 ml, 100 ml, 200 ml or 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Human albumin | 100 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood and blood substitutes (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Solution for infusion 50 mg/1 ml: amp. 10 ml or 20 ml 10 pcs., bot. 50 ml, 100 ml, 200 ml or 400 ml 1 pc.
Marketing Authorization Holder
Chelyabinsk Regional Blood Transfusion Station SUE (Russia)
Dosage Form
|
Albumin | Solution for infusion 50 mg/1 ml: amp. 10 ml or 20 ml 10 pcs., bot. 50 ml, 100 ml, 200 ml or 400 ml 1 pc. |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Human albumin | 50 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood and blood substitutes (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
Solution for infusion 200 g/l: fl. 50 or 100 ml; amp. 10 ml or 20 ml
Marketing Authorization Holder
Chelyabinsk Regional Blood Transfusion Station SUE (Russia)
Dosage Form
|
Albumin | Solution for infusion 200 g/l: fl. 50 or 100 ml; amp. 10 ml or 20 ml |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 l |
| Human albumin | 200 g |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
Infusion solution 10%: 20 ml amp. 10 pcs. or 100 ml, 200 ml bot.
Marketing Authorization Holder
Ivanovo Regional Blood Transfusion Station SIH (Russia)
Dosage Form
|
Albumin 10% | Infusion solution 10%: 20 ml amp. 10 pcs. or 100 ml, 200 ml bot. |
Dosage Form, Packaging, and Composition
Infusion solution in the form of a transparent yellow liquid; a greenish tint is allowed.
| 1 ml | |
| Human albumin | 100 mg |
Excipients: sodium caprylate 3 mg, sodium chloride 5 mg, water for injection up to 1 ml.
20 ml – ampoules (10) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
200 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 5%: amp. 10 or 20 ml, fl. 50 ml, 100 ml, 200 ml or 400 ml
Marketing Authorization Holder
Samara Regional Clinical Blood Transfusion Station (Russia)
Dosage Form
|
Human albumin | Infusion solution 5%: amp. 10 or 20 ml, fl. 50 ml, 100 ml, 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 1 ml |
| Human albumin | 50 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
400 ml – bottles (1) – cardboard packs.
Infusion solution 20%: amp. 10 or 20 ml, bottles 50 ml or 100 ml
Marketing Authorization Holder
Samara Regional Clinical Blood Transfusion Station (Russia)
Dosage Form
|
Human albumin | Infusion solution 20%: amp. 10 or 20 ml, bottles 50 ml or 100 ml |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 1 ml |
| Human albumin | 200 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
50 ml – bottles for blood substitutes (1) – cardboard packs.
100 ml – bottles for blood substitutes (1) – cardboard packs.
Infusion solution 10%: amp. 10 or 20 ml, fl. 50 ml, 100 ml, 200 ml or 400 ml
Marketing Authorization Holder
Samara Regional Clinical Blood Transfusion Station (Russia)
Dosage Form
|
Human albumin | Infusion solution 10%: amp. 10 or 20 ml, fl. 50 ml, 100 ml, 200 ml or 400 ml |
Dosage Form, Packaging, and Composition
| Infusion solution 10% | 1 ml |
| Human albumin | 100 mg |
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
400 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs.
50 ml – bottles (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes – cardboard packs.
50 ml – bottles for blood and blood substitutes – cardboard packs.
Infusion solution 20%: vial 50 ml or 100 ml.
Marketing Authorization Holder
Biotest Pharma, GmbH (Germany)
Dosage Form
|
Human albumin Biotest | Infusion solution 20%: vial 50 ml or 100 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 1 ml |
| Human albumin | 200 mg |
50 ml – vials (1) complete with a plastic holder – cardboard packs.
100 ml – vials (1) complete with a plastic holder – cardboard packs.
Infusion solution 20%: vial 50 ml or 100 ml.
Marketing Authorization Holder
Green Cross Corporation (Republic of Korea)
Dosage Form
|
Human albumin serum | Infusion solution 20%: vial 50 ml or 100 ml. |
Dosage Form, Packaging, and Composition
| Infusion solution 20% | 1 ml |
| Human albumin | 200 mg |
50 ml – vials (1) complete with a plastic holder – cardboard packs.
100 ml – vials (1) complete with a plastic holder – cardboard packs.
Infusion solution 5%: fl. 50 ml or 100 ml
Marketing Authorization Holder
Green Cross Corporation (Republic of Korea)
Dosage Form
|
Human albumin serum | Infusion solution 5%: fl. 50 ml or 100 ml |
Dosage Form, Packaging, and Composition
| Infusion solution 5% | 1 ml |
| Human albumin | 50 mg |
50 ml – bottles (1) complete with a plastic holder – cardboard packs.
100 ml – bottles (1) complete with a plastic holder – cardboard packs.
Infusion solution 20%: fl. 50 ml
Marketing Authorization Holder
Siegardis Rus LLC (Russia)
Manufactured By
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China)
Dosage Form
|
Albumin Sigardis | Infusion solution 20%: fl. 50 ml |
Dosage Form, Packaging, and Composition
Infusion solution transparent, slightly viscous light yellow, green or brown in color, without opalescence.
| 1 ml | |
| Human albumin | 200 mg |
Excipients: sodium caprylate 0.16 mmol/g protein, water for injection up to 1 L.
50 ml – bottles of colorless glass (1) – cardboard packs.
Solution for infusion 100 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs.
Marketing Authorization Holder
Belgorod Regional Blood Transfusion Station OSUHZ (Russia)
Dosage Form
|
Albumin solution | Solution for infusion 100 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Human albumin | 100 mg |
50 ml – bottles for blood and blood substitutes (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
Solution for infusion 50 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs
Marketing Authorization Holder
Belgorod Regional Blood Transfusion Station OSUHZ (Russia)
Dosage Form
|
Albumin solution | Solution for infusion 50 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Human albumin | 50 mg |
50 ml – bottles for blood and blood substitutes (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
Solution for infusion 200 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs.
Marketing Authorization Holder
Belgorod Regional Blood Transfusion Station OSUHZ (Russia)
Dosage Form
|
Albumin solution | Solution for infusion 200 mg/ml: bottle 50 ml, 100 ml, 200 ml, 400 ml 1 pc.; amp. 10 ml, 20 ml 5 or 10 pcs. |
Dosage Form, Packaging, and Composition
| Solution for infusion | 1 ml |
| Human albumin | 200 mg |
50 ml – bottles for blood and blood substitutes (1) – cardboard packs.
100 ml – bottles for blood and blood substitutes (1) – cardboard packs.
200 ml – bottles for blood and blood substitutes (1) – cardboard packs.
400 ml – bottles for blood and blood substitutes (1) – cardboard packs.
10 ml – ampoules (5) – cardboard packs.
10 ml – ampoules (10) – cardboard packs.
20 ml – ampoules (5) – cardboard packs.
20 ml – ampoules (10) – cardboard packs.
![Albumin [Solution] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Albumin [Solution] 2")